21st century science-based, risk-based Pharmaceutical Validation: Current Good Manufacturing Practices

This book is inspired by the pioneers who moulded pharmaceutical validation, like Dr Kenneth Chapman et al, and the USFDA that gave it the much needed fillip with their CGMP for the 21st century initiative.

This book is intended to serve as a bridge between the traditional approach to pharmaceutical
validation and the science-based, risk-based multistage product lifecycle implementation approach currently advocated.

It comprises five parts: each exploring a different, but related, topic in width as in depth.